FIELD: pharmacology.
SUBSTANCE: invention relates to compounds of formula (I)
,
their salts, pharmaceutical compositions, and their use as vasopressin V1a-receptor agonists in the treatment of, for example, complications of cirrhosis, including bacterial peritonitis, HRS2 (type II hepatorenal syndrome) and refractory ascites.
EFFECT: increased efficiency of composition application.
39 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
| SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES AS Rho-KINASE INHIBITORS | 2007 |
|
RU2455302C2 |
| BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES, USEFUL AS RHO-KINASE INHIBITORS | 2009 |
|
RU2532481C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS KINASE 1β-ADRENERGIC RECEPTOR INHIBITORS | 2006 |
|
RU2415855C2 |
| UREA AND SULPHAMIDE DERIVATIVES AS TAFIA INHIBITORS | 2007 |
|
RU2459619C2 |
| NEW CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTINE RECEPTOR | 1997 |
|
RU2180331C2 |
| TRPV1 ANTAGONISTS AND USE THEREOF | 2008 |
|
RU2452733C2 |
| AZAINDOL DERIVATIVES AS FACTOR Xa INHIBITORS | 2004 |
|
RU2330853C2 |
| CYCLOHEXYLAMINIZOQUINOLONE AS Rho-KINASE INHIBITORS | 2006 |
|
RU2440988C2 |
| NOVEL PEPTIDE DERIVATIVES AND USE THEREOF | 2015 |
|
RU2699572C2 |
